Dexcom Inc

مادة اعلانية

Latest Update: 16 Mar 2026 23:59 Abu Dhabi Time.

Market Status: Closed

DXCM

Dexcom Inc

66.34

USD

2.100

3.27%

Open

64.85

Prev Close

64.24

PX_VOLUME

MARKET CAP (M)

DAY RANGE

64.85 - 66.81

52 WEEKS

54.11 - 89.98

Stock Statistics

Yearly Change

-6.19%

Listed Shares (Million)

410.70

Earnings Multiple

31.15

Average 30-day trading volume

4,836,357.15

Price-to-book ratio

9.00

Earnings Per Share

2.14

Previous Dividend Distribution

Dividend Yield

0.00%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		1,259.60	1,209.30	1,157.10	1,036.00	1,113.50	994.20	1,004.30	921.00	1,034.50	975.00
Gross Profit		885.50	731.40	688.80	589.00	709.30	593.80	626.70	561.90	670.30	621.60
Operating Income		415.80	242.50	212.60	133.70	242.40	152.00	158.00	101.10	233.50	205.50
Net Income		267.30	283.80	179.80	105.40	151.70	134.60	143.50	146.40	256.30	120.70
Profit Margin		21.22	23.47	15.54	10.17	13.62	13.54	14.29	15.90	24.78	12.38

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Revenue		4,662.00	4,033.00	3,622.30	2,909.80	2,448.50	1,926.70
Gross Profit		2,894.70	2,491.70	2,297.40	1,889.50	1,704.90	1,302.00
Operating Income		1,011.70	653.50	614.30	405.10	293.90	323.90
Net Income		836.30	576.20	541.50	341.20	216.90	549.70
Profit Margin		17.94	14.29	14.95	11.73	8.86	28.53

Balance Sheet

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Assets		6,339.90	7,500.00	7,327.00	6,751.70	6,484.50	6,353.80	6,799.20	6,482.20	6,264.50	6,596.20
Total Liabilities		3,593.90	4,773.90	4,753.90	4,485.10	4,381.90	4,374.80	4,364.90	4,235.40	4,195.90	4,328.30
Total Equity		2,746.00	2,726.10	2,573.10	2,266.60	2,102.60	1,979.00	2,434.30	2,246.80	2,068.60	2,267.90

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Total Assets		6,339.90	6,484.50	6,264.50	5,391.70	4,933.30	4,290.50
Total Liabilities		3,593.90	4,381.90	4,195.90	3,259.90	2,891.20	2,464.00
Total Equity		2,746.00	2,102.60	2,068.60	2,131.80	2,042.10	1,826.50

Cash Flows Statements

	Period Ending:	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Cash From Operating Activities		294.00	659.90	303.00	183.80	301.40	199.50	279.40	209.20	133.60	269.20
Cash From Investing Activities		306.60	192.80	-63.60	100.20	-303.70	210.30	-188.90	74.80	414.90	-179.50
Cash From Financing Activities		-1,522.20	-175.00	-1.70	12.50	-1.60	-736.50	-1.40	4.70	-631.90	-637.40
Net Change in Cash		-917.80	676.60	254.20	298.80	-15.10	-318.10	88.10	284.90	-77.30	-551.20

	Period Ending:	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash From Operating Activities		1,440.70	989.50	748.50	669.50	442.50	475.60
Cash From Investing Activities		536.00	-207.50	-507.20	-521.50	-216.10	-1,018.00
Cash From Financing Activities		-1,686.40	-734.80	-318.60	-552.50	10.40	912.10
Net Change in Cash		311.80	39.80	-75.80	-410.30	235.40	371.80

* In Million of United States Dollar

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.